Dry Eye Syndrome to Drive Adoption of Artificial Tears

San Francisco, California, July 03, 2017: The increasing number of eye problems among the geriatric population is one of the primary causes leading to the high adoption of artificial tears across the globe, states TMR Research in a research report. The report is titled, “Artificial Tears Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025.”

The swiftly rising global geriatric population has a crucial role to play in the progress of the global market for artificial tears. Aging people are more prone to ophthalmic ailments such as dry eye syndrome as aging weakens the eyes, thus causing several eye problems. This is further resulting in an upsurge in the consumption of artificial years. Furthermore, the market is expected to be benefitted with the rising number of people taking up eye surgeries. The treatment of dry eye, which is a usual condition that occurs post to any eye surgery, is especially boosting the demand for artificial tears. Other than this, their generic application also included being applied in the eye of animals a part of the therapy for treating keratoconjuctivitis sicca.

Some of the various forms of artificial tears include based on raw materials include propylene glycol based tears, polyethylene glycol based, oil based emulsion tears, glycerin based tears, and cellulose derived tears. The segment that is expected to exhibit the leading demand is the segment of glycerin based tears owing to their availability in abundance and the capability to maintain the eye moisture for a long time. Nevertheless, a shift of consumers towards cellulose derived tears is anticipated to be witnessed in the years ahead due to the rise in the number of end users preferring natural products for eye treatment. On the basis of delivery, the two conventional dry eye relief procedures are artificial tears and ointments.

The manufactures of artificial tears are expected to capitalize on the opportunities that are likely to be offered in the near future by the developing countries in Latin America and Asia Pacific. The companies that are operating in the market are focusing on the production of high end products and keeping in mind the needs of its consumer base and end users. Thus, to attain this goal, the players are focusing on intense research and development activities for product diversification.

Generally, artificial tears are referred to as eye drops that are employed for lubricating dry eyes and then help to preserve the moisture present on the outer surface of the eye. This has emerged as an effective solution for people suffering from dry eye and other eye ailments. However, prevailing side effects may restrict the market’s growth to some extent. The leading companies operating in the global artificial tears market are Alcon Inc., Bausch & Lomb, McNEIL-PPC, Santen Pharmaceuticals, Novartis International AG, AbbottMedical Optics Inc., Advanced Vision Research Inc., and Allergan Inc.